Gregory T. Bales to Botulinum Toxins, Type A
This is a "connection" page, showing publications Gregory T. Bales has written about Botulinum Toxins, Type A.
Connection Strength
1.530
-
Sacral Neuromodulation is Preferred over OnabotulinumtoxinA Injection for Overactive Bladder in Women: Con. J Urol. 2017 09; 198(3):500-501.
Score: 0.587
-
Botulinum toxin injection: a review of injection principles and protocols. Int Braz J Urol. 2007 Mar-Apr; 33(2):132-41.
Score: 0.286
-
Intravesical botulinum type A toxin injection in patients with overactive bladder: Trigone versus trigone-sparing injection. Can J Urol. 2006 Oct; 13(5):3291-5.
Score: 0.278
-
Use of botulinum-A toxin for the treatment of refractory overactive bladder symptoms: an initial experience. Urology. 2004 Jun; 63(6):1071-5.
Score: 0.236
-
Botulinum toxin type A inhibits sensory neuropeptide release in rat bladder models of acute injury and chronic inflammation. BJU Int. 2008 Feb; 101(3):366-70.
Score: 0.076
-
Botulinum toxin type a inhibits calcitonin gene-related peptide release from isolated rat bladder. J Urol. 2006 Mar; 175(3 Pt 1):1138-42.
Score: 0.067